Raffles Medical Group Stock EBITDA

RAFLFDelisted Stock  USD 0.74  0.00  0.00%   
Raffles Medical Group fundamentals help investors to digest information that contributes to Raffles Medical's financial success or failures. It also enables traders to predict the movement of Raffles Pink Sheet. The fundamental analysis module provides a way to measure Raffles Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Raffles Medical pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Raffles Medical Group Company EBITDA Analysis

Raffles Medical's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Raffles Medical EBITDA

    
  161.27 M  
Most of Raffles Medical's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Raffles Medical Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition

According to the company disclosure, Raffles Medical Group reported earnings before interest,tax, depreciation and amortization of 161.27 M. This is 81.62% lower than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The ebitda for all United States stocks is 95.86% higher than that of the company.

Raffles EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Raffles Medical's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Raffles Medical could also be used in its relative valuation, which is a method of valuing Raffles Medical by comparing valuation metrics of similar companies.
Raffles Medical is currently under evaluation in ebitda category among its peers.

Raffles Fundamentals

About Raffles Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Raffles Medical Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Raffles Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Raffles Medical Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Consideration for investing in Raffles Pink Sheet

If you are still planning to invest in Raffles Medical Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Raffles Medical's history and understand the potential risks before investing.
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Bonds Directory
Find actively traded corporate debentures issued by US companies